Using a 0.35 T MRI-Linac to Assess Glioblastoma Response to Treatment
Author Information
Author(s): Maziero Danilo, Azzam Gregory Albert, de La Fuente Macarena, Stoyanova Radka, Ford John Chetley, Mellon Eric Albert
Primary Institution: UC San Diego Health and University of Miami Miller School of Medicine
Hypothesis
Can a 0.35 T MRI-Linac system effectively assess glioblastoma response to radiotherapy using dynamic contrast-enhanced MRI?
Conclusion
The study demonstrates that a 0.35 T MRI-Linac can successfully obtain post-contrast 3D-T1w and DCE data to evaluate glioblastoma response to treatment.
Supporting Evidence
- The 3D-T1w contrast-enhancement volumes were visually and volumetrically similar between 0.35 T MRI-Linac and 3 T.
- DCE images showed temporal stability, and Ktrans maps were consistent with patient treatment responses.
- On average, Ktrans values showed a 54% decrease for the responder and an 8.6% increase for the non-responder.
Takeaway
Doctors can use a special MRI machine to see how brain tumors respond to treatment, helping them make better decisions for patients.
Methodology
The study involved acquiring 3D-T1w and DCE data from a flow phantom and two glioblastoma patients using a 0.35 T MRI-Linac, comparing results with a 3 T scanner.
Potential Biases
Potential bias due to the small number of patients and the reliance on a single imaging technique.
Limitations
The study had a small sample size and the temporal resolution of DCE data was relatively long.
Participant Demographics
Two patients with glioblastoma, one male aged 64 and one female aged 57.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website